Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
JAAPA : Official Journal of the American Academy of Physician Assistants|November 13, 2021
PA- and NP-led Ommaya clinics to manage leptomeningeal carcinomatosisErika N Leese, Jamie L Weeder, Jesse J Manikowski, et al.
Radiation Oncology (London, England)|June 8, 2021
Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experienceIrina Kapitanova, Sharmi Biswas, Sabrina Divekar, et al.
Advances in Radiation Oncology|November 9, 2017
The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicityRachel B Jimenez, Brian M Alexander, Anand Mahadevan, et al.
The Oncologist|February 27, 2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatmentRobert Haddad, Roy B Tishler, Charles M Norris, et al.
Cancer|July 15, 2017
Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide reviewSusanna W L de Geus, Mariam F Eskander, Gyulnara G Kasumova, et al.
Neuro-Oncology Practice|May 31, 2021
Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapyNa Tosha N Gatson, Mina Makary, Shane P Bross, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Frameless angiogram-based stereotactic radiosurgery for treatment of arteriovenous malformationsXing-Qi Lu, Anand Mahadevan, George Mathiowitz, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2015
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancersDeepa Rangachari, Norihiro Yamaguchi, Paul A VanderLaan, et al.
Surgery|May 11, 2017
Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapyGyulnara G Kasumova, Mariam F Eskander, Susanna W L de Geus, et al.
Radiation Oncology (London, England)|October 1, 2025
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatmentJonathan W Lischalk, Vianca F Santos, Brianna Vizcaino, et al.
Pageof 10